fashion -WSS

fashion

author：comprehensive 2025-09-03 05:36:15 - browse：2532

The Chamber of Commerce in downtown Washington, DC. — The U.S. Chamber of Commerce sued to stop a new Medicare drug price negotiation program from going into effect. Adobe

WASHINGTON — Attorneys for the U.S. Chamber of Commerce and the federal government sparred Friday over whether drugmakers have enough say in Medicare’s new drug price negotiation program, in the first oral arguments in a lawsuit challenging the new law.

The two sides debated two questions: whether the Chamber of Commerce would be sufficiently injured by the law to file a lawsuit, and whether the negotiation program was a violation of drugmakers’ due process rights.

The hearing was held in the U.S. District Court for the Southern District of Ohio, and Judge Michael Newman, a Trump nominee, presided. Newman didn’t ask any questions of the attorneys, so the hearing didn’t provide any hints about which way he might be leaning on the issues.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Psychedelics group wrestles with new pharma identity
Next article： Senate committee advances SCOTUS ethics bill after alleged justice misconduct

WSS

Reporting on presidential health from Reagan to Trump and Biden

New study raises questions about niacin and heart health

Flagship Pioneering startup Sonata Therapeutics lays off 21

Bipartisan group of lawmakers warns of a rising Chinese threat to U.S. biotech

I learned firsthand about improving diversity in clinical trials

Stanford president's case begs question: Who takes blame?

knowledge

fashion

Wikipedia

At least 13 dead in Texas as scorching temps continue

EF3 tornado rips through North Carolina amid extreme weather nationwide

In age of alternative facts, a scholarly course on calling out crap

Hospitals struggle to profit from CAR

Sports medicine is finally prioritizing gender equality

Judge rejects Trump's request to move Stormy Daniels hush

Medicare proposal to cover medical devices draws a mixed reaction

DeSantis talks Trump, trans issues and 'what wokeness is'

Virginia high school admissions case could be legal follow

Researchers tackle phage therapy hurdles for wider adoption

focus

Indian pharmaceutical industry in denial over drug

Tesla recalling nearly 16,000 of its 2021

Congress may force more Covid

Secretariat’s lessons for human medicine

Study identifies new proteins linked to dementia risk 25 years later

Readout LOUD podcast: Pharma in Washington, Alnylam, and Gilead

hotspot

knowledge

hotspot

explore